The phrase "honorary fees" is correct and can be used in written English.
It refers to fees or payments that are given as an honor or token of appreciation, rather than as a requirement or expectation. It is commonly used in academic or professional settings, where individuals may receive honorary degrees or be granted honorary positions. Example: The university awarded Dr. Smith an honorary degree in recognition of her contributions to the field of medicine. The honorary fees associated with the degree will go towards funding future research projects.
It was a prodigious effort from a team that did not cost a single penny in transfer fees and honorary mentions should go to the two centre-halves, Michael Nelson and Josh Coulson, for their backs-to-the-wall resilience.
JK-D declared consulting fees and honoraries from Novartis.
But though schools still offer honorary degrees and even speaking fees in rare cases, some campuses have taken the wooing to a more visible level.
He has not received any fees, reimbursement or honorary in relation to this work.
Special discounts on all Oxford University Press Medical publications All members of ERA-EDTA who have regularly paid their current annual membership fee (as well as Honorary Members and Senior Members) are entitled to receive a 35% discount on all Oxford University Press medical publications.
In 1810 and 1811 he lectured to large audiences at Dublin (on agricultural chemistry, the elements of chemical philosophy, geology) and received £1,275 in fees, as well as the honorary degree of LL.D., from Trinity College.
A small number of male artists paid a fee of $2 per year to be honorary members, so that they could have access to a trained pool of professional models.
While honorary memberships to Shoal Creek are free, regular membership cost $35,000 in initiation fees.
Gunnar Folprecht received research funding (Merck KGaA), honoraries for ad-hoc advisory boards (Merck KGaA, Genentech, Sanofi-Aventis, Lilly, Bayer, Bristol-Myers Squibb) and lecture fees (Merck KGaA, Genentech, Sanofi-Aventis, Lilly).
The Committee reported that fees and costs had increased significantly since the last review under Charles I, a number of expensive honorary positions had been created, and on many occasions court officers had not known what the correct fees were.
